Clinical trial

Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis

NCT01895439

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-10-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2012-10-01Date precision: month

Registry last updated2017-05-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

Autologous Mesenchymal Stem CellsBIOLOGICAL

Sponsors & collaborators

University of Jordanlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01895439 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.